Author:
Thakkar Jigisha P.,Prabhu Vikram C.,Peters Katherine B.,Lukas Rimas V.
Reference74 articles.
1. Is next-generation sequencing alone sufficient to reliably diagnose gliomas?;Kam;J Neuropathol Exp Neurol,2020
2. cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC);Louis;Acta Neuropathol,2018
3. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant;Louis;Acta Neuropathol,2018
4. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV";Brat;Acta Neuropathol,2018
5. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF(V600E) mutation;Ellison;Acta Neuropathol,2019
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献